Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03444-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Zi-Yi Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510000, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Programmed Cell Death 1 Receptor, Signal Transduction, Coix. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The objective of this research was to investigate how the combination of semen coicis extract and PD-1 inhibitors can potentially work together to enhance the anti-tumor effects, with a focus on understanding the underlying mechanism. METHODS: We obtained the active components and specific targets of semen coicis in the treatment of NSCLC from various databases, namely TCMSP, GeneCard, and OMIM. By utilizing the STRING database and Cytoscape software, we established a protein interaction network (PPI) for the active ingredient of semen coicis and the target genes related to NSCLC. To explore the potential pathways involved, we conducted gene ontology (GO) and biological pathway (KEGG) enrichment analyses, which were further supported by molecular docking technology. Additionally, we conducted cyto-inhibition experiments to verify the inhibitory effects of semen coicis alone or in combination with a PD-1 inhibitor on A549 cells, along with examining the associated pathways. Furthermore, we investigated the synergistic mechanism of these two drugs through cytokine release experiments and the PD-L1 expression study on A549 cells. RESULTS: Semen coicis contains two main active components, Omaine and (S)-4-Nonanolide. Its primary targets include PIK3R1, PIK3CD, PIK3CA, AKT2, and mTOR. Molecular docking experiments confirmed that these ingredients and targets form stable bonds. In vitro experiments showed that semen coicis demonstrates inhibitory effects against A549 cells, and this effect was further enhanced when combined with PD-1 inhibitors. PCR and WB analysis confirmed that the inhibition of the PI3K-AKT-mTOR pathway may contribute to this effect. Additionally, semen coicis was observed to decrease the levels of IFN-γ, IL-6, and TNF-α, promoting the recovery of the human anti-tumor immune response. And semen coicis could inhibit the induced expression of PD‑L1 of A549 cells stimulated by IFN‑γ as well. CONCLUSION: Semen coicis not only has the ability to kill tumor cells directly but also alleviates the immunosuppression found in the tumor microenvironment. Additionally, it collaboratively enhances the effectiveness of PD-1 inhibitors against tumors by blocking the activation of PI3K-AKT-mTOR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
- Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
- Department of Pulmonary and Critical Care Medicine, Dongguan Hospital Affiliated to Guangzhou University of Chinese Medicine, Dongguan, 523000, China.
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China.
- Department of Pulmonary and Critical Care Medicine, Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Foshan, 528000, China.
- Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510000, China. rsclxhgzcum@163.com.
Zitieren
APA
Fu, Z. Y., Huang, Y., Lian, L. S., Huang, H. T., Zhan, S. F., Cai, Y., Li, J. X., & Liu, X. H. (2024). Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03444-1
Vancouver
Fu ZY, Huang Y, Lian LS, Huang HT, Zhan SF, Cai Y, et al. Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03444-1
BibTeX
@article{Fu2024,
author = {Fu, Zi-Yi and Huang, Ying and Lian, Le-Shen and Huang, Hui-Ting and Zhan, Shao-Feng and Cai, Yan and Li, Jun-Xiong and Liu, Xiao-Hong},
title = {Potential of semen coicis in enhancing the anti-tumor effects of PD-1 inhibitor on A549 cell lines by blocking the PI3K-AKT-mTOR pathway},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03444-1}
}
EUVIMED